CONCORD BIOTECH LIMITED Share Price & Technical Analysis
CONCORDBIO · ₹1,349 (+0.73%)
Healthcare / Biotechnology
₹1,349
+0.73%
Concord Biotech Limited, a biopharma company, engages in the research and development, manufacture, market, and sale of pharmaceutical products in India and internationally. The company provides fermentation based active pharmaceutical ingredients in immunosuppressants, anti-bacterial, oncology, antifungal, and other therapeutic areas. It also offers tacrolimus, mycophenolate mofetil, mycophenolat…
Price chart
Seasonality
Jul has 1 positive and 1 negative years (last 4 years shown)
1% return in 2026, 17% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -13% | 7% | -15% | 7% | -8% | 22% | – | – | – | – | – | – | 1% |
| 25 | -3% | -27% | 11% | -8% | 15% | 4% | -4% | -4% | -2% | -12% | -2% | -5% | -37% |
| 24 | -1% | -1% | 5% | 7% | -12% | 5% | 6% | 1% | 20% | -10% | 16% | 3% | 38% |
| 23 | – | – | – | – | – | – | – | 8% | 11% | 5% | 16% | 9% | 50% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Emerging · Uptrend
Concord Biotech Limited, a biopharma company, engages in the research and development, manufacture, market, and sale of pharmaceutical products in India and internationally. The company provides fermentation based active pharmaceutical ingredients in immunosuppressants, anti-bacterial, oncology, antifungal, and other therapeutic areas. It also offers tacrolimus, mycophenolate mofetil, mycophenolate sodium, cyclosporine, sirolimus, voclosporin, and pimecrolimus for immunosuppressants therapeutic segment; and temsirolimus, everolimus, romidepsin, doxorubicin, mitomycin, midostaurin, and dactinomycin for oncology therapeutic segment. In addition, the company provides mupirocin, mupirocin calcium, polymyxin B sulfate, fidaxomicin, vancomycin hydrochloride, and teicoplanin for anti-bacterial applications; anidulafungin, caspofungi, micafungin sodium, and nystatin for anti-fungal therapeutic segment; and lovastatin and pravastatin sodium for other applications. Further, it develops daptomycin for anti-infectives applications; and epirubicin, idarubicin, and pirarubicin for oncology therapeutic segment. Additionally, the company provides contract research and manufacturing services in the areas of fermentation and semi-synthesis products. Concord Biotech Limited was incorporated in 1984 and is based in Ahmedabad, India.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
₹138.89B
P/E ratio
53.66
52W high
₹1,980
52W low
₹987.0
Volume
35,962
Beta
0.42
Related stocks in Healthcare
Ngl Fine-chem Ltd.
₹3,165
Coral Laboratories Ltd.
₹593.3
Frequently asked questions
- What is CONCORD BIOTECH LIMITED share price today?
- CONCORD BIOTECH LIMITED (CONCORDBIO) last traded around ₹1,349 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does CONCORDBIO have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for CONCORDBIO. Download the app for real-time alerts.
- How can I analyze CONCORD BIOTECH LIMITED stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.